• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性积液的检测:端粒酶检测与细胞学检查的比较

Detection of malignant effusions: comparison of a telomerase assay and cytologic examination.

作者信息

Braunschweig R, Yan P, Guilleret I, Delacretaz F, Bosman F T, Mihaescu A, Benhattar J

机构信息

Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

出版信息

Diagn Cytopathol. 2001 Mar;24(3):174-80. doi: 10.1002/1097-0339(200103)24:3<174::aid-dc1036>3.0.co;2-8.

DOI:10.1002/1097-0339(200103)24:3<174::aid-dc1036>3.0.co;2-8
PMID:11241900
Abstract

Telomerase is inactive in most somatic cells, but has been found to be reactivated in a majority of cancers. Our principal goal was to test whether the presence of telomerase activity concurred with positive cytology, and was thus of potential use in detecting cancer cells in effusions. The telomeric repeat amplification protocol (TRAP) assay and cytological examination were performed in a blinded fashion on 91 unselected effusions, for which laboratory processing was done according to standard procedures. In our series, 30% (27/91) of samples were found to be malignant by cytology. Of these, 19 (70%) were also positive in the TRAP assay. Of the 8 telomerase-negative cytology-positive samples, RNA integrity was generally poor, indicating suboptimal sample conservation for molecular analysis. Negative cytology in the presence of telomerase activity was observed in 17 effusions. Of these, 11 were from patients with advanced cancer, and thus a diagnosis of malignant effusion should be suspected. The TRAP assay for telomerase activity holds promise in the analysis of effusions, but its routine use as an adjunct to cytology awaits further confirmation of its positive predictive value.

摘要

端粒酶在大多数体细胞中无活性,但已发现在大多数癌症中被重新激活。我们的主要目标是测试端粒酶活性的存在是否与阳性细胞学结果一致,因此是否可用于检测积液中的癌细胞。端粒重复序列扩增法(TRAP)检测和细胞学检查以盲法对91例未经选择的积液进行,这些积液的实验室处理按照标准程序进行。在我们的系列研究中,30%(27/91)的样本经细胞学检查发现为恶性。其中,19例(70%)在TRAP检测中也呈阳性。在8例端粒酶阴性但细胞学阳性的样本中,RNA完整性普遍较差,表明用于分子分析的样本保存欠佳。在17例积液中观察到端粒酶活性存在但细胞学阴性的情况。其中,11例来自晚期癌症患者,因此应怀疑为恶性积液。TRAP法检测端粒酶活性在积液分析中有应用前景,但其作为细胞学辅助手段的常规应用有待进一步证实其阳性预测价值。

相似文献

1
Detection of malignant effusions: comparison of a telomerase assay and cytologic examination.恶性积液的检测:端粒酶检测与细胞学检查的比较
Diagn Cytopathol. 2001 Mar;24(3):174-80. doi: 10.1002/1097-0339(200103)24:3<174::aid-dc1036>3.0.co;2-8.
2
Pitfalls in TRAP assay in routine detection of malignancy in effusions.TRAP检测在常规检测积液中恶性肿瘤时的陷阱。
Diagn Cytopathol. 2001 Oct;25(4):225-30. doi: 10.1002/dc.2043.
3
Telomerase activity in effusions: a comparison between telomere repeat amplification protocol in situ and conventional telomere repeat amplification protocol assay.积液中的端粒酶活性:端粒重复序列扩增法原位检测与传统端粒重复序列扩增法检测的比较
Arch Pathol Lab Med. 2008 Dec;132(12):1896-902. doi: 10.5858/132.12.1896.
4
Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids.通过原位杂交检测体液细胞中的人端粒酶RNA组分。
Acta Cytol. 2005 Jan-Feb;49(1):31-7. doi: 10.1159/000326092.
5
Cytological diagnosis and telomerase activity of cells in effusions of body cavities.体腔积液中细胞的细胞学诊断及端粒酶活性
Oncol Rep. 1999 Jan-Feb;6(1):199-203. doi: 10.3892/or.6.1.199.
6
Telomere repeat amplification protocol (TRAP) in situ reveals telomerase activity in three cell types in effusions: malignant cells, proliferative mesothelial cells, and lymphocytes.
Mod Pathol. 2005 Feb;18(2):189-96. doi: 10.1038/modpathol.3800278.
7
Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.基于酶联免疫吸附测定(ELISA)的端粒重复扩增法(TRAP)检测恶性胸腔积液的局限性:与细胞学检查的比较
Cytopathology. 2005 Oct;16(5):227-32. doi: 10.1111/j.1365-2303.2005.00259.x.
8
Gene expression analysis of the catalytic subunit of human telomerase (hEST2) in the differential diagnosis of serous effusions.人端粒酶催化亚基(hEST2)基因表达分析在浆液性积液鉴别诊断中的应用
Diagn Mol Pathol. 2001 Mar;10(1):60-5. doi: 10.1097/00019606-200103000-00010.
9
Telomerase activity in pleural effusions: diagnostic significance.
J Clin Oncol. 1998 Feb;16(2):567-73. doi: 10.1200/JCO.1998.16.2.567.
10
Telomerase activity analyzed with TRAP in situ provides additional information in effusions remaining equivocal after immunocytochemistry and hyaluronan analysis.通过端粒酶重复扩增法原位分析端粒酶活性,可为免疫细胞化学和透明质酸分析后仍存疑的积液提供额外信息。
Diagn Cytopathol. 2014 Dec;42(12):1051-7. doi: 10.1002/dc.23165. Epub 2014 Apr 1.

引用本文的文献

1
Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review).间皮瘤中的端粒与端粒酶:病理生理学、生物标志物及新兴治疗策略(综述)
Int J Oncol. 2025 Mar;66(3). doi: 10.3892/ijo.2025.5729. Epub 2025 Feb 21.
2
Construction and analysis of expression profile of exosomal lncRNAs in pleural effusion in lung adenocarcinoma.构建并分析肺腺癌胸腔积液外泌体 lncRNAs 的表达谱。
J Clin Lab Anal. 2022 Dec;36(12):e24777. doi: 10.1002/jcla.24777. Epub 2022 Nov 25.
3
Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion.
活性氧调节因子 1 与腺苷脱氨酶联合检测在鉴别 NSCLC 相关恶性胸腔积液中的临床价值。
J Clin Lab Anal. 2020 Mar;34(3):e23091. doi: 10.1002/jcla.23091. Epub 2019 Nov 10.
4
Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.鉴定和诊断非小细胞肺癌患者恶性胸腔积液中胸膜蛋白多糖和血清蛋白多糖的价值。
J Clin Lab Anal. 2019 Sep;33(7):e22943. doi: 10.1002/jcla.22943. Epub 2019 Jul 3.
5
Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer-associated malignant pleural effusion.联合检测胸腔积液中Midkine、胸腔积液腺苷脱氨酶及胸腔积液糖类抗原125在鉴别非小细胞肺癌相关恶性胸腔积液中的临床价值
J Clin Lab Anal. 2018 Oct;32(8):e22576. doi: 10.1002/jcla.22576. Epub 2018 May 23.
6
Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion.联合检测血清乳酸脱氢酶/胸水腺苷脱氨酶及胸水癌胚抗原在鉴别恶性胸腔积液中的临床价值
J Clin Lab Anal. 2017 Sep;31(5). doi: 10.1002/jcla.22106. Epub 2016 Dec 15.
7
Diagnostic yield of cytologic analysis of pericardial effusion in dogs.犬心包积液细胞学分析的诊断率
J Vet Intern Med. 2014 Jan-Feb;28(1):66-71. doi: 10.1111/jvim.12253. Epub 2013 Nov 16.
8
Telomerase activity assay for the diagnosis of malignant pleural effusion: A meta-analysis.端粒酶活性检测用于诊断恶性胸腔积液:一项荟萃分析。
Exp Ther Med. 2012 Sep;4(3):487-492. doi: 10.3892/etm.2012.623. Epub 2012 Jun 26.
9
Telomerase detection in the diagnosis and prognosis of cancer.端粒酶检测在癌症的诊断和预后中的应用。
Cytotechnology. 2004 Jun;45(1-2):61-74. doi: 10.1007/s10616-004-5126-0.
10
Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies.检测腹水中端粒酶活性对消化道恶性肿瘤诊断的优势。
World J Gastroenterol. 2004 Sep 1;10(17):2468-71. doi: 10.3748/wjg.v10.i17.2468.